May 29, 2019
Rose
In the first day of the high-profile opioid trial, Oklahoma Attorney General Mike Hunter confronted what many legal experts have predicted will be the highest hurdle in the case: connecting one manufacturer of opioids to the cascading harms wrought by the entire industry. Johnson & Johnson fought back, though, arguing that the state itself looked the other way as its own drug review board and prescription monitoring program for years neglected to swoop down on sources of diverted opioids.
from Kaiser Health News http://bit.ly/2VXZN16
May 29, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
HHS Says Reporting ‘Inaccurate’ About Potential Changes To Fetal Tissue Research Funding For UCSF- Some Of Most Vulnerable Slip Through N.Y. Program That Helps Those With Mental Illness Live Independently
- Shackling Women Prisoners During Childbirth Could Be Outlawed In New Federal Legislation
- Debt, ‘Ballooning’ Rents Lead Texas’ Biggest Nursing Home Provider To File For Bankruptcy
- Judge Considers Delaying CVS-Aetna Merger, Citing Potential Anti-Competitive Harms
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment